Effectiveness of pH measurements in predicting feeding tube placement: an update

N Metheny1, L Reed, L Wiersema

  • 1St. Louis University School of Nursing, MO.

Nursing Research
|November 1, 1993
PubMed

Insights

pH testing of feeding tube aspirates accurately distinguishes gastric from intestinal placement. This method aids in confirming correct nasogastric tube positioning and preventing complications.

Area of Science:

  • Clinical Medicine
  • Gastroenterology
  • Medical Devices

Background:

  • Accurate feeding tube placement is critical for patient safety and effective nutrition delivery.
  • Differentiating between gastric, intestinal, and respiratory placement can be challenging.
  • Current methods for confirmation may have limitations.

Purpose of the Study:

  • To evaluate the efficacy of pH testing of aspirates for determining feeding tube placement.
  • To differentiate between gastric and intestinal tube placement.
  • To distinguish gastric tube placement from inadvertent respiratory tract placement.

Main Methods:

  • A clinical study involving 605 subjects with feeding tubes.
  • Collection and pH measurement of 794 aspirates from nasogastric and nasointestinal tubes.
  • Concurrent confirmation of tube position using X-rays.

Main Results:

  • pH values reliably differentiated gastric from intestinal feeding tube placement (p < .0001).
  • Gastric aspirates (85%) showed pH 0-6.0; intestinal aspirates (87%) showed pH > 6.0.
  • Four cases of respiratory tract placement had pH values > 6.5.

Conclusions:

  • pH testing of feeding tube aspirates is a valuable, non-invasive tool for confirming placement.
  • This method enhances the safety and accuracy of feeding tube utilization.
  • pH monitoring can help prevent potentially serious complications associated with malpositioned tubes.

Related Concept Videos

Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).